BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence - Iamjan, Sri-arun; Thanoi, Samur; Watiktinkorn, Paritat; Nudmamud-Thanoi, Sutisa; Reynolds, Gavin P (Pharmacogenomics, 2015)
Keywords: Addictions; Amphetamine-Related Disorders - epidemiology; Amphetamine-Related Disorders - genetics; Amphetamines; Asian Continental Ancestry Group - genetics; BDNF; Brain-derived neurotrophic factor; Brain-Derived Neurotrophic Factor - genetics; Central Nervous System Stimulants; Deoxyribonucleic acid; Diagnostic and Statistical Manual of Mental Disorders; DNA; Dopamine; Dosage and administration; Drug abuse; Drug metabolism; Gene Frequency; Gene polymorphism; Genetic aspects; Genetic polymorphisms; Genotype; Genotype & phenotype; Health aspects; Humans; Mental disorders; Methamphetamine; methamphetamine dependence; Minority & ethnic groups; Polymerase chain reaction; Polymorphism; Polymorphism, Genetic - genetics; Psychiatry; Psychoses, Substance-Induced - epidemiology; Psychoses, Substance-Induced - genetics; Psychosis; Risk factors; rs6265; Schizophrenia; Thailand - epidemiology; Thailand; United States--US; methamphetamine dependence; polymorphism; rs6265; BDNF; psychosis